Cocaine and able: drug runners innovate

Can peace hold in Lebanon while Hizbullah remains? Our correspondent weighs the balance of power between government forces and the Iran-backed militia. The resale value of Labubus is falling – who cares? And remembering Swedish death-clearer, Margareta Magnusson. Watch extended c ...  Show more

Oil prices are at their highest since 2022, as a swift end to the Iran conflict proves elusive. Yet, our commodities editor says, markets do not yet yet recognise how deep the supply shock is. Who will contest next year’s pivotal election in France? And great expectations in Braz ...  Show more

More than 36,000 migrants crossed the English Channel in small boats last year. Our correspondent investigates the increasingly sophisticated business strategies of the criminals who smuggle them. As the planet heats, wildfires in East Asia are becoming fiercer and more frequent ...  Show more

Car and phone theft were once the preserve of petty crooks in London. Now they underpin a vast and spreading international criminal network. Why you should consider consulting a new oracle for making big life decisions: an economist. And the cult of the private chef.Listen to wha ...  Show more

Drugs in America often cost more than three times as much as those elsewhere. But Donald Trump’s plan to cut prescription costs and impose tariffs may have unintended consequences for consumers. Inside North Korea’s crypto-heist: from hermit kingdom to hacking kingdom (10:45). An ...  Show more

More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs th ...